In prostate cancer, a trial comparing conventional- versus high-dose conformal radiotherapy has shown that increasing the dose can improve outcome, with only slight increases in toxicity.
Related Articles
Senza categoria
Jean-Claude Horiot: the innocent inquisitor
voices
Scanners, zappers and nanobots: are patient groups missing a trick?
Systems & Services